Emmaus Life Sciences Inc (EMMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 10,759 | 6,753 | 5,930 | 4,939 | 4,287 |
| Cost of Goods | 508 | 429 | 645 | 540 | 396 |
| Gross Profit | 10,251 | 6,324 | 5,285 | 4,399 | 3,891 |
| Operating Expenses | 7,433 | 7,918 | 7,348 | 5,599 | 5,727 |
| Operating Income | 3,326 | -1,165 | -1,418 | -660 | -1,440 |
| Interest Expense | 1,793 | 1,502 | 1,469 | 1,520 | 1,287 |
| Other Income | -3,125 | -735 | 3,103 | 1,754 | -5,983 |
| Pre-tax Income | -1,592 | -3,402 | 216 | -426 | -8,710 |
| Income Tax | -34 | 49 | 16 | -35 | 182 |
| Net Income Continuous | -1,558 | -3,451 | 200 | -391 | -8,892 |
| Net Income | $-1,558 | $-3,451 | $200 | $-391 | $-8,892 |
| EPS Basic Total Ops | -0.03 | -0.07 | 0.01 | -0.01 | -0.18 |
| EPS Basic Continuous Ops | -0.03 | -0.07 | 0.00 | -0.01 | -0.18 |
| EPS Diluted Total Ops | -0.03 | -0.07 | 0.01 | -0.01 | -0.18 |
| EPS Diluted Continuous Ops | -0.03 | -0.07 | 0.00 | -0.01 | -0.18 |
| EBITDA(a) | $4,019 | $-574 | $-893 | $-115 | $-1,068 |